Logo image of IAS

INTEGRAL AD SCIENCE HOLDING (IAS) Stock Fundamental Analysis

USA - NASDAQ:IAS - US45828L1089 - Common Stock

10.24 USD
+0.01 (+0.1%)
Last: 11/6/2025, 8:00:02 PM
10.24 USD
0 (0%)
After Hours: 11/6/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, IAS scores 6 out of 10 in our fundamental rating. IAS was compared to 95 industry peers in the Media industry. IAS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IAS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IAS had positive earnings in the past year.
In the past year IAS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IAS reported negative net income in multiple years.
Each year in the past 5 years IAS had a positive operating cash flow.
IAS Yearly Net Income VS EBIT VS OCF VS FCFIAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.76%, IAS is in the better half of the industry, outperforming 77.89% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.19%, IAS is in the better half of the industry, outperforming 65.26% of the companies in the same industry.
With a Return On Invested Capital value of 4.52%, IAS perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IAS is significantly below the industry average of 8.55%.
The 3 year average ROIC (2.15%) for IAS is below the current ROIC(4.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.76%
ROE 5.19%
ROIC 4.52%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
IAS Yearly ROA, ROE, ROICIAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10

1.3 Margins

The Profit Margin of IAS (9.79%) is better than 80.00% of its industry peers.
IAS has a better Operating Margin (12.70%) than 70.53% of its industry peers.
The Gross Margin of IAS (78.03%) is better than 91.58% of its industry peers.
IAS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.7%
PM (TTM) 9.79%
GM 78.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
IAS Yearly Profit, Operating, Gross MarginsIAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

IAS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IAS has been increased compared to 1 year ago.
IAS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IAS has been reduced compared to a year ago.
IAS Yearly Shares OutstandingIAS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
IAS Yearly Total Debt VS Total AssetsIAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IAS has an Altman-Z score of 11.36. This indicates that IAS is financially healthy and has little risk of bankruptcy at the moment.
IAS has a Altman-Z score of 11.36. This is amongst the best in the industry. IAS outperforms 96.84% of its industry peers.
There is no outstanding debt for IAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.36
ROIC/WACC0.53
WACC8.54%
IAS Yearly LT Debt VS Equity VS FCFIAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

IAS has a Current Ratio of 3.64. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
IAS has a better Current ratio (3.64) than 94.74% of its industry peers.
IAS has a Quick Ratio of 3.64. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
IAS has a better Quick ratio (3.64) than 94.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.64
IAS Yearly Current Assets VS Current LiabilitesIAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

IAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 3300.00%, which is quite impressive.
Looking at the last year, IAS shows a quite strong growth in Revenue. The Revenue has grown by 14.40% in the last year.
Measured over the past years, IAS shows a quite strong growth in Revenue. The Revenue has been growing by 19.95% on average per year.
EPS 1Y (TTM)3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)14.4%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.66%

3.2 Future

IAS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.52% yearly.
Based on estimates for the next years, IAS will show a quite strong growth in Revenue. The Revenue will grow by 11.50% on average per year.
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y11.5%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IAS Yearly Revenue VS EstimatesIAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IAS Yearly EPS VS EstimatesIAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.12 indicates a quite expensive valuation of IAS.
Compared to the rest of the industry, the Price/Earnings ratio of IAS indicates a somewhat cheap valuation: IAS is cheaper than 62.11% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 25.67. IAS is around the same levels.
Based on the Price/Forward Earnings ratio of 25.83, the valuation of IAS can be described as expensive.
IAS's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 31.86, IAS is valued at the same level.
Industry RankSector Rank
PE 30.12
Fwd PE 25.83
IAS Price Earnings VS Forward Price EarningsIAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IAS's Enterprise Value to EBITDA ratio is in line with the industry average.
63.16% of the companies in the same industry are more expensive than IAS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.63
EV/EBITDA 11.61
IAS Per share dataIAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IAS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IAS's earnings are expected to grow with 33.52% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y31.29%
EPS Next 3Y33.52%

0

5. Dividend

5.1 Amount

No dividends for IAS!.
Industry RankSector Rank
Dividend Yield N/A

INTEGRAL AD SCIENCE HOLDING

NASDAQ:IAS (11/6/2025, 8:00:02 PM)

After market: 10.24 0 (0%)

10.24

+0.01 (+0.1%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners58.61%
Inst Owner Change0.32%
Ins Owners0.82%
Ins Owner Change32.12%
Market Cap1.71B
Revenue(TTM)569.84M
Net Income(TTM)55.76M
Analysts54
Price Target11.8 (15.23%)
Short Float %6.54%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)115.58%
Min EPS beat(2)78.78%
Max EPS beat(2)152.38%
EPS beat(4)3
Avg EPS beat(4)63.39%
Min EPS beat(4)-16.56%
Max EPS beat(4)152.38%
EPS beat(8)5
Avg EPS beat(8)-248.99%
EPS beat(12)9
Avg EPS beat(12)-94.66%
EPS beat(16)11
Avg EPS beat(16)-72.28%
Revenue beat(2)2
Avg Revenue beat(2)2.98%
Min Revenue beat(2)2.82%
Max Revenue beat(2)3.15%
Revenue beat(4)3
Avg Revenue beat(4)0.88%
Min Revenue beat(4)-4.27%
Max Revenue beat(4)3.15%
Revenue beat(8)7
Avg Revenue beat(8)1.54%
Revenue beat(12)11
Avg Revenue beat(12)1.62%
Revenue beat(16)15
Avg Revenue beat(16)2.28%
PT rev (1m)-11.01%
PT rev (3m)-13.24%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)1.3%
EPS NY rev (1m)0.26%
EPS NY rev (3m)29.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 30.12
Fwd PE 25.83
P/S 3
P/FCF 15.63
P/OCF 11.25
P/B 1.59
P/tB 8.07
EV/EBITDA 11.61
EPS(TTM)0.34
EY3.32%
EPS(NY)0.4
Fwd EY3.87%
FCF(TTM)0.66
FCFY6.4%
OCF(TTM)0.91
OCFY8.89%
SpS3.42
BVpS6.43
TBVpS1.27
PEG (NY)0.58
PEG (5Y)N/A
Graham Number7.02
Profitability
Industry RankSector Rank
ROA 4.76%
ROE 5.19%
ROCE 6.59%
ROIC 4.52%
ROICexc 4.93%
ROICexgc 34.04%
OM 12.7%
PM (TTM) 9.79%
GM 78.03%
FCFM 19.19%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
ROICexc(3y)2.35%
ROICexc(5y)N/A
ROICexgc(3y)21.82%
ROICexgc(5y)N/A
ROCE(3y)3.13%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 63.58%
Cap/Sales 7.46%
Interest Coverage 250
Cash Conversion 109.06%
Profit Quality 196.08%
Current Ratio 3.64
Quick Ratio 3.64
Altman-Z 11.36
F-Score6
WACC8.54%
ROIC/WACC0.53
Cap/Depr(3y)52.63%
Cap/Depr(5y)38.91%
Cap/Sales(3y)6.28%
Cap/Sales(5y)5.42%
Profit Quality(3y)639.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue 1Y (TTM)14.4%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.66%
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y11.5%
EBIT growth 1Y64.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255%
EBIT Next 3Y66.13%
EBIT Next 5Y42.29%
FCF growth 1Y46.8%
FCF growth 3Y15.7%
FCF growth 5YN/A
OCF growth 1Y49.87%
OCF growth 3Y22.84%
OCF growth 5YN/A

INTEGRAL AD SCIENCE HOLDING / IAS FAQ

Can you provide the ChartMill fundamental rating for INTEGRAL AD SCIENCE HOLDING?

ChartMill assigns a fundamental rating of 6 / 10 to IAS.


What is the valuation status of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

ChartMill assigns a valuation rating of 5 / 10 to INTEGRAL AD SCIENCE HOLDING (IAS). This can be considered as Fairly Valued.


What is the profitability of IAS stock?

INTEGRAL AD SCIENCE HOLDING (IAS) has a profitability rating of 6 / 10.


What are the PE and PB ratios of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

The Price/Earnings (PE) ratio for INTEGRAL AD SCIENCE HOLDING (IAS) is 30.12 and the Price/Book (PB) ratio is 1.59.


Can you provide the financial health for IAS stock?

The financial health rating of INTEGRAL AD SCIENCE HOLDING (IAS) is 8 / 10.